Peak Group: Subsidiary Peak Pharmaceuticals passed the drug GMP compliance inspection.

The Peak Group announcement: its wholly-owned subsidiary, Peak Pharmacy, has received the "Notice of Compliance Inspection for Drug GMP" issued by the Zhejiang Provincial Food and Drug Administration. The production and quality management of the tablet production lines G01 workshop, G02 workshop, and production line A comply with the requirements of the "Drug Production Quality Management Specifications"; the production and quality management of the eye preparation production line A also comply with relevant regulations. Peak Pharmacy has obtained the "Drug Registration Certificate" for the corresponding drugs, and the results of this inspection are beneficial for ensuring product quality and production capacity.